Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Grant revenue	$ 28,004	$ 1,850	$ 95,439	$ 26,165
Operating expenses:
Research and development	5,110,805	2,762,170	10,372,409	8,040,422
General and administrative	3,690,010	2,351,007	6,936,205	4,998,422
Total operating expenses	8,800,815	5,113,177	17,308,614	13,038,844
Loss from operations	(8,772,811)	(5,111,327)	(17,213,175)	(13,012,679)
Other income:
Other income	20,606	441,546	77,783	672,824
Interest income	5,880	14,069	13,065	29,568
Total other income	26,486	455,615	90,848	702,392
Net loss	$ (8,746,325)	$ (4,655,712)	$ (17,122,327)	$ (12,310,287)
Net loss per share, basic and diluted (in Dollars per share)	$ (0.34)	$ (0.18)	$ (0.67)	$ (0.51)
Weighted average common shares outstanding, basic and diluted (in Shares)	25,373,706	25,369,144	25,372,749	24,261,032
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Net loss	$ (8,746,325)	$ (4,655,712)	$ (17,122,327)	$ (12,310,287)
Other comprehensive loss:
Foreign currency translation adjustments	(105,434)	(27,334)	(58,200)	(65,292)
Comprehensive loss	$ (8,851,759)	$ (4,683,046)	$ (17,180,527)	$ (12,375,579)